Prof. Dr. Christopher Goldring, Institute of Translational Medicine, Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK

Drug-induced liver injury: how can we improve prediction using better models and biomarkers

Drug-induced liver injury: how can we improve prediction using better models and biomarkers